This is consistent with a mix of sepsis and direct viral invasion. Thus, COVID-19 has well-known effects on the respiratory system, with the majority of victims requiring hospitalization for pneumonia of various severity, nonetheless, almost all other organ systems can be impacted. According to the World Health Organization (WHO) data published on 1 July 2022, there have been 545,226,550 confirmed cases of COVID-19 all over the world.
#BIOFIRE DIAGNOSTICS DRIVERS#
One of the main drivers of the sepsis diagnostics market is the increasing prevalence of the COVID-19 pandemic. Therefore, the market for sepsis diagnostics is estimated to grow at a significant CAGR during the forecast period from 2022 to 2027. The sepsis diagnostics market is witnessing positive growth owing to various factors such as the increasing prevalence of the COVID-19 pandemic, a rise in the geriatric population, the increasing prevalence of bacterial infections such as tuberculosis, and the surge in the regulatory approvals for the technologically advanced sepsis diagnostics products. The global sepsis diagnostics market was valued at USD 644.48 million in 2021, growing at a CAGR of 9.60% during the forecast period from 2022 to 2027 to reach USD 1114.82 million by 2027. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation.Sepsis Diagnostics Market By Techniques Type (Immunoassay, Molecular Diagnosis, Microbiology, Flow Cytometry, And Others), By Test Type (Laboratory Testing And Point Of Care Testing), By Product Type (Assays & Reagents And Instruments & Kits), By Pathogen (Bacterial, Fungal, And Others), By End-User (Hospitals, Pathology Laboratories, And Others), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increasing prevalence of covid-19 pandemic and a rise in the geriatric population Plenary sessions will explore artificial intelligence-based clinical prediction models, advances in multiplex technologies, human brain organogenesis, building trust between the public and healthcare experts, and direct mass spectrometry techniques.Īt the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of the McCormick Place Convention Center in Chicago with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.ĭedicated to achieving better health through laboratory medicine, AACC brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science.
The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 24-28. Today, members of the AACC Board of Directors will personally visit all 35 organizations at their booths to deliver the awards.Ībout the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo Golden honored the association's top supporters. Congratulations to this year's winners, and our sincerest thanks for enabling AACC to accomplish its goals."ĪACC's 35 top corporate supporters were recognized during the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo at an invitation-only Corporate Recognition Reception on Monday, July 25 in Chicago. "It is because of their support that we are able to provide laboratory medicine professionals with the resources they need to adapt to the evolving healthcare landscape. "We at AACC are delighted to show our gratitude toward these companies," said AACC CEO Mark J. Clinical Laboratory News Print Advertiser of the Year
0 kommentar(er)
